A new study would be done to evaluate a lower dosage that performed better than higher dose in AstraZeneca’s studies, that will be an additional global trial to assess the efficacy of its COVID-19 vaccine. AstraZeneca’s, Chief Executive Pascal Soriot has been quoted saying this to the Bloomberg media.
According to the Bloomberg News report, Soriot said the efficacy of the vaccine is high so the global trial will be done on the less patients “International study, but this one could be faster because we know efficacy is high so we need a smaller number of patients.”
Flu virus in raw milk : The risk of flu virus in raw milk can…
https://youtu.be/YgTAoQVJEQo?si=Bwfkhe1qqnrTiWRs Why Diabetes Patients Have High Blood Pressure: Understanding the Connection Diabetes and high blood…
Side Effects of Tea & Cigarette: The combination of tea and cigarettes is a common…
Constipation Home Remedy: Is constipation bothering you during winter? The cold weather and changes in…
Eye Problem Linked to Alzheimer: Did you know that Alzheimer's disease could affect your vision?…
Paracetamol, also known as acetaminophen, is one of the most commonly used over-the-counter medications for…